Compare DeepSeek R1 0528 by DeepSeek against GPT-5.4 Pro by OpenAI, context windows of 164K vs 1.1M, tested across 14 shared challenges. Updated March 2026.
9 fights queued
Generate a unique and simple recipe with common ingredients.
A fast, sweet-savory noodle dish made from 7 pantry staples.
Water for boiling/thinning the sauce doesn’t count.
If you want, I can also give you a 7-ingredient sweet dessert recipe.
Create a starter plan for improving long-term health.
Here’s a simple, beginner-friendly 1-month health and longevity plan built around 3 key areas:
The goal is consistency, not perfection. Start small and make the habits easy enough to keep.
Goal: Eat more whole foods without going on a strict diet.
Goal: Move daily and build a basic strength habit.
Goal: Improve sleep and lower daily stress.
Focus this week: Show up, even if it feels small.
Beginner strength routine
Do 2 rounds:
Focus this week: Make the habits feel automatic.
Focus this week: Consistency beats intensity.
Focus this week: Choose the habits you can continue next month.
Use this as your “minimum win” list:
By the end of the month, a great result would be:
That is a strong start for better health and longevity.
If you want, I can also turn this into a printable weekly checklist or a very simple meal + workout template.
Develop a cutting-edge 3-month longevity plan for a biohacker.
Below is a 12-week, high-performance longevity protocol designed for a healthy biohacker who wants to improve lifespan-relevant markers, physical performance, and cognitive output at the same time.
Use it as a data-driven template, not dogma. If you have medical conditions, take medications, are pregnant, have a history of eating disorders, or have issues with blood pressure, glucose regulation, kidney/liver function, or anxiety/bipolar spectrum symptoms, run the plan through a clinician first.
For actual longevity, the biggest levers are still:
The “biohacker edge” comes from:
Get these in Week 0, then repeat a smaller set at Week 6 and Week 12:
Best stack:
Goal: fix the basics, build recovery capacity, gather data.
Goal: improve metabolic flexibility, endurance, power, and work capacity.
Goal: personalize based on actual data, deload appropriately, and retest.
This is better for most people than rigid keto 7 days/week.
Eat a lot of:
Minimize:
Do not stack:
…all at once. That’s not longevity; that’s overreaching.
If you menstruate and notice cycle disruption, worse sleep, or poor recovery:
Use carbs strategically rather than fearing them.
Aim roughly for:
If you spike:
These are the highest-value additions for most people.
| Supplement | Dose | Timing | Notes |
|---|---|---|---|
| Creatine monohydrate | 3–5 g/day | anytime | Strong evidence for strength, cognition, and recovery |
| Omega-3 (EPA+DHA total) | 1.5–2 g/day | with meals | Prefer tested, high-quality brand |
| Magnesium glycinate or taurate | 200–400 mg elemental | 30–60 min before bed | Adjust for GI tolerance |
| Vitamin D3 | 1,000–2,000 IU/day | with fat-containing meal | Better if guided by labs |
| Vitamin K2 (MK-7) | 90–180 mcg/day | with D3 | Avoid if on warfarin unless clinician approves |
| Glycine | 3 g | pre-bed | Sleep support, simple and low-risk |
| Protein powder | as needed | post-workout or meal gap | Use only to hit protein target |
| Electrolytes | individualized | morning / sauna / low-carb days | Especially sodium on keto or heavy sweat days |
On low-carb, fasting, or sauna-heavy days, sodium needs often go up. A common target is higher sodium intake, but this should be individualized if you have hypertension, kidney issues, or fluid-sensitive conditions.
These are reasonable if you tolerate the basics well.
| Supplement | Dose | Timing | Cycle |
|---|---|---|---|
| Sulforaphane (or broccoli sprouts) | sprouts: 30–60 g/day or standardized product | morning / lunch | continuous |
| Taurine | 1–3 g/day | evening or post-workout | continuous |
| Urolithin A | 500–1,000 mg/day | morning | 8 weeks on, 4 off |
| Spermidine | 1–2 mg/day | with meal | continuous if tolerated |
| CoQ10 (ubiquinol) | 100–200 mg/day | breakfast | useful if >35, statin use, or heavy training |
| Curcumin phytosome | 500 mg/day | with meal | use more for joint/inflammation issues |
| NAC | 600 mg/day | evening or rest days | 3–5 days/week; avoid around workouts if possible |
Use on work-heavy days, not necessarily every day.
| Supplement | Dose | Timing | Cycle |
|---|---|---|---|
| Caffeine | 50–150 mg | morning only | avoid within 8–10h of bed |
| L-theanine | 100–200 mg | with caffeine | smooths stimulation |
| Citicoline | 250 mg | morning | 5 days on / 2 off |
| Rhodiola rosea | 200–300 mg standardized extract | morning | 5 on / 2 off, or 6 weeks on / 2 off |
| Bacopa monnieri | 300 mg/day standardized | evening or with meal | better for longer-term memory, not acute focus |
Evidence is mixed. If you like N=1 work, keep this clearly separate.
| Supplement | Dose | Notes |
|---|---|---|
| NR or NMN | 250–500 mg AM | evidence mixed; if trying it, run 8 weeks on / 4 off |
| Ca-AKG | 1 g twice daily | early human data is still limited |
I’d treat these as optional experiments, not cornerstones.
For longevity + performance, this is the sweet spot:
Target 150–210 min/week total.
Use one of:
If you’re advanced, use a lactate meter once to find your Zone 2. That’s one of the best “biohacker upgrades” for endurance programming.
1x/week is enough.
Bike/rower is usually safer than all-out running.
Longevity is not just muscle—it’s also power, tendon, and bone.
1–2x/week, before lifting:
Skip if you’re deconditioned or injury-prone.
Target:
…reduce training intensity that day.
If you snore, wake unrefreshed, or your wearable shows repeated low oxygen trends, rule out sleep apnea. That is a massive longevity lever.
One of the better evidence-backed “advanced recovery” tools.
Hydrate well and replace electrolytes.
Optional. Good for alertness and resilience, but don’t overrate it.
Avoid cold immediately after hypertrophy-focused lifting if muscle gain is a priority. Better:
This is high value and underused.
Good times:
If you want a more experimental layer:
Evidence is much stronger for stress/attention support than for direct longevity.
Proceed normally if:
Reduce total volume ~20% if:
Do:
Recovery day only if:
Check:
ApoB matters more than “biohacker ideology.”
If LDL/ApoB rises substantially:
Reasonable improvements:
Pause or reduce the plan if you get:
That usually means you stacked too many stressors:
If you only do 10 things, do these:
If you want, I can turn this into a fully scheduled day-by-day 12-week calendar with:
Write a pro-level buy-side investment memo with valuation and diligence questions.
LedgerLift (LLLT) — IC Memo
Recommendation: Pass
12-month PT range: $40–$47
2-sentence thesis: LedgerLift looks like a good business but only an average stock here: retention is strong (94% GRR, 123% NRR), the model is mostly subscription, and margins are inflecting, but at $46 the shares already discount a lot of the good news. Our DCF is below spot in all three scenarios ($17–$42/sh), while comps only support a fair-value band around the low/mid-$40s to low-$50s; that is not enough edge for a clean long, and the KPI quality is too good for a high-conviction short.
At $46, LLLT’s market cap is $8.74B; net of $1.4B cash, EV is $7.34B. On FY26 base estimates, that is 7.4x EV/revenue and 37x EV/EBIT.
LedgerLift sells B2B spend management + AP automation software to mid-market enterprises. The model is attractive: 92% subscription revenue, consolidated 78% GM, and 18% operating margin in FY25, with services acting as implementation/enablement.
Why it wins
Why now
What looks good
What could be wrong / what I would pressure-test
UFCF formula:
UFCF = EBIT × (1 – 23% tax) + D&A – capex – ΔNWC
with D&A = 2.5% of revenue, capex = 3.0% of revenue, and ΔNWC = 1.0% of incremental revenue.
| Base case | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | 992 | 1,171 | 1,346 | 1,521 | 1,704 |
| EBIT | 198 | 258 | 323 | 380 | 443 |
| UFCF | 146 | 191 | 240 | 284 | 331 |
| Bull case | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | 1,025 | 1,240 | 1,463 | 1,683 | 1,902 |
| EBIT | 215 | 298 | 381 | 471 | 552 |
| UFCF | 159 | 221 | 283 | 352 | 413 |
| Bear case | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | 951 | 1,075 | 1,193 | 1,312 | 1,431 |
| EBIT | 162 | 193 | 227 | 262 | 300 |
| UFCF | 118 | 142 | 167 | 194 | 223 |
| Scenario | WACC | Terminal g | PV of 2026-30 UFCF | PV of TV | DCF EV | + Net Cash | Equity Value | Value / Share |
|---|---|---|---|---|---|---|---|---|
| Bear | 12% | 2% | 588 | 1,291 | 1,879 | 1,400 | 3,279 | $17.3 |
| Base | 10% | 3% | 870 | 3,023 | 3,893 | 1,400 | 5,293 | $27.9 |
| Bull | 9% | 4% | 1,068 | 5,583 | 6,651 | 1,400 | 8,051 | $42.4 |
Takeaway: even the bull DCF is below today’s $46. That makes a fundamental long hard to underwrite at the current price.
Peer medians:
Using FY26 base as NTM:
| Multiple | FY26 Metric ($m) | Median Multiple | Implied EV ($m) | Implied Equity ($m) | Value / Share |
|---|---|---|---|---|---|
| EV / Revenue | 992 | 9.0x | 8,930 | 10,330 | $54.4 |
| EV / EBIT | 198 | 35.0x | 6,945 | 8,345 | $43.9 |
Adjustment view: LLLT deserves some discount to median revenue multiple because of its 8% services mix, mid-market exposure, skewed concentration, and only-okay 18-month CAC payback. On EBIT, it probably deserves around median, maybe slightly below, because profitability is improving but not yet elite. That yields a practical comps band of roughly $41–$52/sh.
Bottom line: comps say roughly fair, DCF says overvalued.
Conclusion: Pass. High-quality software asset, but valuation already reflects much of the good KPI story, and our DCF does not support paying up from here.
Build a simplified LBO with returns and sensitivities.
Below is a simplified LBO build for HarborTech Services (HTS).
All figures in $m unless noted.
Rounding: tables are rounded; IRR/MOIC use unrounded math.
Assumptions used in the model:
[ \text{Cash Taxes} = 25% \times \max(0,\ \text{EBITDA} - \text{cash interest}) ]
[ \text{FCF after debt service} = \text{EBITDA} - \text{TL cash int} - \text{Mezz cash int} - \text{cash taxes} - \text{capex} - \Delta NWC - 4.8 ]
That FCF is fully used for optional Term Loan paydown.
| FY | Revenue | EBITDA | TL cash int | Mezz cash int | Cash taxes | Capex | ΔNWC | FCF after debt service (= TL sweep) | Ending Term Loan | Ending Mezz |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 972.0 | 136.1 | 43.2 | 21.6 | 17.8 | 29.2 | 0.4 | 19.1 | 456.1 | 183.6 |
| 2027 | 1,040.0 | 156.0 | 41.0 | 22.0 | 23.2 | 31.2 | 0.3 | 33.4 | 417.9 | 187.3 |
| 2028 | 1,102.4 | 176.4 | 37.6 | 22.5 | 29.1 | 33.1 | 0.3 | 49.0 | 364.1 | 191.0 |
| 2029 | 1,157.6 | 191.0 | 32.8 | 22.9 | 33.8 | 34.7 | 0.3 | 61.7 | 297.6 | 194.8 |
| 2030 | 1,215.4 | 206.6 | 26.8 | 23.4 | 39.1 | 36.5 | 0.3 | 75.8 | 217.0 | 198.7 |
[ 2,147.870 - 415.720 = 1,732.150 ]
Initial equity invested: 808.8
Equity MOIC:
[
1,732.150 \div 808.8 = 2.14x
]
Equity IRR (5 years):
[
\left(\frac{1,732.150}{808.8}\right)^{1/5} - 1 = 16.5%
]
Assumption for this grid: only FY2030 EBITDA margin changes (to 16% / 17% / 18% on the same FY2030 revenue), and FY2030 taxes / debt paydown update accordingly.
| FY2030 EBITDA margin \ Exit multiple | 9.5x | 10.5x | 11.5x |
|---|---|---|---|
| 16% | 11.7% | 14.6% | 17.2% |
| 17% | 13.6% | 16.5% | 19.1% |
| 18% | 15.3% | 18.2% | 20.8% |
Contract renewal / repricing risk
“Recurring” revenue can still re-bid or reset on price, especially with sophisticated data-center customers.
Customer concentration risk
A few hyperscale / colo customers could drive a disproportionate share of EBITDA.
Labor availability and wage inflation
Skilled HVAC technicians are hard to hire/retain; wage pressure can delay margin expansion.
SLA / uptime liability risk
HTS is mission-critical; service failures can trigger credits, penalties, reputational damage, and lost renewals.
Leverage + exit multiple risk
Entry leverage is meaningful (5.5x, including mezz with PIK); if growth/margins underperform and exit multiple compresses, equity returns can fall quickly.
Underwrite leverage only to recurring service EBITDA
Haircut or exclude any non-recurring project/install EBITDA when sizing debt and valuation.
Use more equity / less mezz if diligence is mixed
Especially if top-customer renewal visibility or labor retention is weak.
Keep strict cash control
Full excess-cash sweep, no dividends, and ideally a springing maintenance covenant / minimum liquidity test.
Improve contract economics
Push for multi-year terms, CPI/labor escalators, parts pass-throughs, and auto-renewal mechanics.
Protect field execution capacity
Fund technician retention programs, training, and backup subcontractor/OEM coverage to reduce SLA miss risk.
If you want, I can also turn this into a compact IC memo format with an investment recommendation and bull/base/bear summary.
Design an innovative, multi-component dish worthy of a 3-star Michelin restaurant.
Below is a dish designed in the language of a contemporary 3-star tasting menu: precise, seasonal, technically layered, and centered on a pairing that feels surprising at first, then inevitable.
Kombu-Cured Turbot with White Chocolate Beurre Blanc, Fermented Green Tomato Fluid Gel, Charred Baby Leeks, Pickled Green Strawberries, Douglas Fir Oil, Mussel–Sea Lettuce Crunch, and Crispy Turbot Skin
Serves: 4 tasting-menu portions
Style: Savory fish course
Core unusual pairing: turbot + white chocolate + Douglas fir
The white chocolate is used not as sweetness, but as a cocoa-butter-rich textural bridge between cultured butter and the natural sweetness of pristine fish.
“A Walk from Shore to Forest After Rain.”
This dish moves from the sea inward. Turbot provides clean Atlantic salinity and gelatin-rich luxury. A restrained white chocolate beurre blanc softens and rounds the sauce without turning dessert-like. Douglas fir contributes resinous citrus, as if the sea air were drifting into conifer woodland. Fermented green tomato and green strawberry bring “unripe” brightness and tension. Charred leeks evoke driftwood and embers. Mussel–sea lettuce crunch returns the palate to iodine and tide.
The plate should feel simultaneously marine, green, and luminous.
Helpful, though not all essential:
The kombu cure lightly seasons the flesh, tightens texture, and adds glutamates without obscuring the fish.
Use white chocolate sparingly. You want silk and roundness, not sweetness. A couverture with clean dairy notes and moderate sugar works best.
A vivid, tart, savory green gel that acts like the acid line in the dish.
If you have a chamber vacuum sealer, vacuum-compress the strawberries in the cooled pickle for a denser texture and jewel-like translucency.
Douglas fir gives notes of citrus peel, green resin, and mountain air.
This gives salinity, crunch, and a deep marine echo without adding heaviness.
Use a wide, warm, matte off-white or pale stoneware plate. Negative space matters.
Serve extra beurre blanc tableside from a small sauceboat. This immediately elevates the experience.
If you want, I can also turn this into:
Identify weak claims in a startup pitch deck and suggest concrete improvements.
Identify failure modes, race conditions, and scaling bottlenecks in a collaborative document editor architecture.
Navigate a complex pharmaceutical CEO ethical dilemma with legal, financial, and safety considerations.
